At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...
Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...
Critics of seed oils, like RFK Jr., say they are toxic and fueling high rates of chronic diseases. Such claims baffle ...
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...
Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...
A polarizing New York policy to treat people with mental illness is ineffective and racially biased, according to a report ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP ...
The company bearing Boston’s name has approximately 10,000 employees in Minnesota, doubling in the past 15 years. And it’s ...
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration.
Border czar Tom Homan is not backing away from his vow of “bringing hell” to Boston, saying that Mayor Michelle Wu “should be standing beside” him in the Trump administration’s ...
Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Program for Hepatitis C Virus (HCV)Patient Enrollment in Global Phase 3 HCV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback